Recommended protocol: Washout: 20 to 25 days Starting dose: 1mg weekly Week 5: escalate to 2mg Week 9: escalate to 4mg Week 13: escalate to 8mg Week 17: consider 12mg based on response and tolerance This protocol follows the standard retatrutide peptide dosage chart exactly, treating you similarly to a GLP-1 naive individual
Front-load protein early in meals when you can eat more
In the Phase 2 trial, the most commonly reported adverse events were gastrointestinal in nature including nausea, vomiting, diarrhoea, and constipation consistent with the side effect profile seen with other GLP-1-based therapies
This study was aimed to design stable and functional fusion proteins consisting of new protease-resistant GLP-1 mutants (mGLP1) genetically fused to DARPin as a critical step toward developing long-acting GLP-1 receptor agonists
Optimizing other aspects of your protocol While managing skin sensitivity, do not neglect other protocol components
The listed SingleCare price references the price of generic drugs if available
